v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total Dentsply Sirona Equity
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Beginning Balance at Dec. 31, 2024 $ 1,943 $ 1,942 $ 3 $ 6,640 $ (835) $ (730) $ (3,136) $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 19 20     20     (1)
Other comprehensive (loss) income 71 71       71    
Stock-based compensation expense 10 10   10        
Funding of employee stock purchase plan 2 2   (3)     5  
Restricted stock unit distributions (3) (3)   (17)     14  
Restricted stock unit dividends 0     1 (1)      
Cash dividends declared ($0.16 per share) (32) (32)     (32)      
Ending Balance at Mar. 31, 2025 2,010 2,010 3 6,631 (848) (659) (3,117) 0
Beginning Balance at Dec. 31, 2024 1,943 1,942 3 6,640 (835) (730) (3,136) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (25)              
Other comprehensive (loss) income 89              
Ending Balance at Jun. 30, 2025 1,961 1,960 3 6,638 (925) (641) (3,115) 1
Beginning Balance at Mar. 31, 2025 2,010 2,010 3 6,631 (848) (659) (3,117) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (44) (45)     (45)     1
Other comprehensive (loss) income 18 18       18    
Stock-based compensation expense 9 9   9        
Restricted stock unit distributions 0 0   (2)     2  
Cash dividends declared ($0.16 per share) (32) (32)     (32)      
Ending Balance at Jun. 30, 2025 1,961 1,960 3 6,638 (925) (641) (3,115) 1
Beginning Balance at Dec. 31, 2025 1,340 1,339 3 6,644 (1,564) (639) (3,105) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (10) (10)     (10)      
Other comprehensive (loss) income (16) (16)       (16)    
Stock-based compensation expense 8 8   8        
Funding of employee stock purchase plan 1 1   (5)     6  
Restricted stock unit distributions (4) (4)   (31)     27  
Ending Balance at Mar. 31, 2026 1,319 1,318 3 6,616 (1,574) (655) (3,072) 1
Beginning Balance at Dec. 31, 2025 1,340 1,339 3 6,644 (1,564) (639) (3,105) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 26              
Other comprehensive (loss) income (17)              
Treasury shares purchased (12)              
Ending Balance at Jun. 30, 2026 1,351 1,351 3 6,619 (1,537) (656) (3,078) 0
Beginning Balance at Mar. 31, 2026 1,319 1,318 3 6,616 (1,574) (655) (3,072) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 36 37     37     (1)
Other comprehensive (loss) income (1) (1)       (1)    
Stock-based compensation expense 9 9   9        
Treasury shares purchased (12) (12)         (12)  
Restricted stock unit distributions 0     (6)     6  
Ending Balance at Jun. 30, 2026 $ 1,351 $ 1,351 $ 3 $ 6,619 $ (1,537) $ (656) $ (3,078) $ 0